July 22, 2024 | 10:30
Imexpharm Corporation has announced its interim results for the first six months of 2024.
May 20, 2024 | 15:10
Imexpharm Pharmaceutical JSC proudly received the “Vietnam Pharmaceutical Star” award for the second time today.
April 26, 2024 | 16:37
Imexpharm Corporation (Imexpharm), a pioneering leader in Vietnam’s pharmaceutical industry, held its AGM at the Hilton Saigon Hotel on April 26.
April 22, 2024 | 08:00
At a macro level in which there is still complexity, the pharmaceutical industry is expected to continue witnessing positive business results in 2024.
April 02, 2024 | 08:00
Imexpharm Corporation announced its business results on March 27, for the fiscal year ending December 31, 2023.
March 22, 2024 | 14:04
Imexpharm Pharmaceutical JSC (IMP) teamed up with Nha Trang People's Committee to plant 500 trees along Ring Road 2 on March 18.
February 27, 2024 | 11:16
IMP has signed a strategic cooperation agreement with Genuone Sciences Inc.
January 23, 2024 | 10:15
Despite a challenging 2023, the pharmaceutical industry remains healthy thanks to the breakthroughs of leading pharmaceutical companies.
December 28, 2023 | 14:18
Imexpharm has scored top honours in corporate governance.
December 28, 2023 | 11:20
SK Investment Vina III, a subsidiary of South Korea’s third-largest conglomerate SK Group, is looking to acquire a 65 per cent stake in Imexpharm Pharmaceutical.
November 30, 2023 | 14:05
Imexpharm Pharmaceutical has been named in the top 5 companies with the best working environment in Vietnam.
November 25, 2023 | 17:38
With the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become an industry leader.
March 01, 2022 | 18:00
After four decades of development, Imexpharm Corporation has reaffirmed its position as a market leader in Vietnam’s pharmaceutical industry by investing in sustainable technology and human resources.
September 23, 2021 | 08:00
In August, Imexpharm Corporation recognised a decrease of 12 per cent in revenue and 14 per cent in profit due to social distancing.
June 15, 2021 | 20:43
SK Investment Vina III Pte., Ltd. has acquired 3.4 million shares of Imexpharm Pharmaceutical JSC to raise its ownership at the firm to 29.22 per cent.